APHKX
Price
$59.49
Change
-$0.27 (-0.45%)
Updated
Jun 22 closing price
Net Assets
44.35B
IIIAX
Price
$14.93
Change
+$0.03 (+0.20%)
Updated
Jun 22 closing price
Net Assets
704.16M
Interact to see
Advertisement

APHKX vs IIIAX

APHKX vs IIIAX Comparison Chart in %
View a ticker or compare two or three
VS
APHKX vs. IIIAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APHKX is a Buy and IIIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
APHKX has more cash in the bank: 44.4B vs. IIIAX (704M). IIIAX pays higher dividends than APHKX: IIIAX (2.53) vs APHKX (1.57). APHKX was incepted earlier than IIIAX: APHKX (20 years) vs IIIAX (18 years). IIIAX (1.08) is less costly to investors than APHKX (0.97). APHKX is a more actively managed with annual turnover of: 24.70 vs. IIIAX (4.00). IIIAX has a lower initial minimum investment than APHKX: IIIAX (0) vs APHKX (1000000). IIIAX annual gain was more profitable for investors over the last year : 23.86 vs. APHKX (17.86). IIIAX return over 5 years is better than : 48.41 vs. APHKX (39.77).
APHKXIIIAXAPHKX / IIIAX
Total Expense Ratio0.970.94103%
Annual Report Gross Expense Ratio0.971.0890%
Fund Existence20 years18 years-
Gain YTD10.82410.113107%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets44.4B704M6,307%
Annual Yield % from dividends1.572.5362%
Returns for 1 year17.8623.8675%
Returns for 3 years43.7557.6476%
Returns for 5 years39.7748.4182%
Returns for 10 years119.83141.2885%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TICRX26.31N/A
N/A
Nuveen Large Cap Responsible Eq A
RYMSX24.03N/A
N/A
Guggenheim Multi-Hedge Strategies P
AWSCX15.80N/A
N/A
Invesco Global Core Equity C
MSAAX22.88N/A
N/A
Morgan Stanley Inst Passport ovrs eq C
PEGEX20.10N/A
N/A
PGIM Jennison Mid-Cap Growth R2